Business ❯ Corporate Law ❯ Legal Compliance

Regulatory Issues

Market Regulations Corporate Accountability Federal Securities Laws Litigation Strategies Securities and Exchange Commission Customs Regulations Market Disclosures Litigation

7 ARTICLES

3mo ago

Erasca Faces Securities Suit Over ERAS-0015 After Patent Claim and Trial Death Disclosures

Investors say April disclosures of a Revolution Medicines patent letter and a Phase 1 patient death undercut Erasca’s prior preclinical claims and triggered a fight for lead-plaintiff control.

4 ARTICLES

last yr.

Regulatory Issues

Erasca Faces Securities Suit Over ERAS-0015 After Patent Claim and Trial Death Disclosures

Nutex Health Class Actions Reach Lead-Plaintiff Deadline as Law Firms Rally Investors